EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

DELP Treatment on Vision and Retinal Microcirculation in Patients With Acute Ischemic Stroke: Report of Five Cases and Literature Review

Ning Li, Ronghua Hong, Hua You, Feiping Xu, Qingjun Zhang, Yiwen Lin, Yuting Su, Danmei Lan, Lingjing Jin iD, Junhui She iD

Therapeutic Apheresis and Dialysis · 2025

DOI: 10.1002/1744-9987.70102 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Ning Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shanghai Jing'an District Shibei Hospital, Shanghai, China. Hauptthemen laut MEDLINE: Ischemic Stroke. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission, National Clinical Key Specialty Project Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The delipid extracorporeal lipoprotein filter from plasma (DELP) treatment can effectively reduce blood lipid, increase blood flow, and improve neurological deficits in patients with acute ischemic stroke (AIS). However, its effect on vision and retinal microcirculation in stroke patients has never been reported.

Methods

Between November 2023 and June 2024, five patients underwent DELP treatment as a routine adjuvant therapy for AIS. Detailed ophthalmological examinations, including best corrected visual acuity (BCVA) and optical coherence tomography angiography (OCTA), were performed on them one day prior to and 1–3 days following the DELP treatment.

Results

Among the ten eyes examined, six had diabetic retinopathy (DR), two had dry age‐related macular degeneration (dAMD), one had idiopathic epiretinal membrane (iERM), and one was normal. Surprisingly, after DELP treatment, the BCVA improved by 0.2LogMAR in six eyes, 0.1LogMAR in three eyes, and remained unchanged in one eye. The vessel density (VD) in the fovea increased in six eyes, remained unchanged in three eyes, and decreased in one eye. The non‐perfusion area (NPA) in the superficial capillary plexus (SCP) decreased in six eyes, remained unchanged in two eyes, and increased in two eyes. The NPA in the deep capillary plexus (DCP) decreased in eight eyes and remained unchanged in two eyes. A small amount of bleeding occurred in Patient 3's right eye, and no other adverse events were observed post‐treatment.

Conclusions

In this case series, the DELP treatment showed a potentially significant therapeutic effect on the BCVA and retinal microcirculation in AIS patients with good safety and provided a rationale for further investigation. At the same time, this treatment may provide an effective option for the treatment of eye diseases such as DR, iERM, and AMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeHumansMicrocirculationAgedMaleFemaleVisual AcuityMiddle AgedRetinal VesselsTomography, Optical CoherenceAged, 80 and over

Stichwörter der Autor:innen

DELPacute ischemic strokecases reportretinal microcirculationvision

Autor:innen und Institutionen

  • Department of Neurology, Shanghai Jing'an District Shibei Hospital, Shanghai, China.
  • Department of Neurology and Neurological Rehabilitation, Shanghai Disabled Persons' Federation Key Laboratory of Intelligent Rehabilitation Assistive Devices and Technologies, Yangzhi Rehabilitation Hospital, School of…
  • Department of Ophthalmology, Shanghai Jing'an District Shibei Hospital, Shanghai, China.
  • Collaborative Innovation Center for Brain Science, Tongji University, Shanghai, China.
  • Clinical Center for Brain and Spinal Cord Research, Tongji University, Shanghai, China.

ORCID-Profile: Lingjing Jin, Junhui She

Förderung

  • National Key Research and Development Program of China
  • Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
  • National Clinical Key Specialty Project Foundation
  • Shanghai Municipal Hospital Development Center
  • National Natural Science Foundation of China
  • Shanghai Blue Cross Hospital Co., Ltd. and Shanghai Tongji University Educationg Development Foundation
  • Shanghai Jing'an District Science and Technology Commission and Jing'an District Health Commission

Zitieren

APA

Li, N., Hong, R., You, H., Xu, F., Zhang, Q., Lin, Y., Su, Y., Lan, D., Jin, L., & She, J. (2025). DELP Treatment on Vision and Retinal Microcirculation in Patients With Acute Ischemic Stroke: Report of Five Cases and Literature Review. Therapeutic Apheresis and Dialysis. https://doi.org/10.1002/1744-9987.70102

Vancouver

Li N, Hong R, You H, Xu F, Zhang Q, Lin Y, et al. DELP Treatment on Vision and Retinal Microcirculation in Patients With Acute Ischemic Stroke: Report of Five Cases and Literature Review. Therapeutic Apheresis and Dialysis. 2025. doi:10.1002/1744-9987.70102

BibTeX
@article{Li2025,
  author = {Li, Ning and Hong, Ronghua and You, Hua and Xu, Feiping and Zhang, Qingjun and Lin, Yiwen and Su, Yuting and Lan, Danmei and Jin, Lingjing and She, Junhui},
  title = {DELP Treatment on Vision and Retinal Microcirculation in Patients With Acute Ischemic Stroke: Report of Five Cases and Literature Review},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2025},
  doi = {10.1002/1744-9987.70102}
}
Kostenlos starten →